Back to the main directory
Press Release
- Use of Castle Biosciences’ DecisionDx®-Melanoma Test Significantly Reduces Unnecessary SLNB Procedures, Latest Findings from Prospective, Multicenter DECIDE Study Presented at Dermato-Onco2024 by BusinessWire
- Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS by GlobeNewsWire
- Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024 by GlobeNewsWire
- Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference by GlobeNewsWire
- Kamada to Announce Third Quarter and Nine-Months Ended September 30, 2024 Financial Results and Host Conference Call on November 13, 2024 by GlobeNewsWire
- Kaltura Announces Financial Results for Third Quarter 2024 by GlobeNewsWire
- Astec Reports Third Quarter 2024 Results by GlobeNewsWire
- Olema Oncology to Participate in Upcoming Investor Conferences by GlobeNewsWire
- CECO Environmental Announces Upcoming Investor Conferences by GlobeNewsWire
- Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update by GlobeNewsWire
- Sprott Announces Third Quarter 2024 Results by GlobeNewsWire
- Stella-Jones annonce une offre publique de rachat dans le cours normal des activités by GlobeNewsWire
- ScottsMiracle-Gro Reports Fiscal 2024 Fourth Quarter and Full-Year Results by GlobeNewsWire
- Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates by GlobeNewsWire
- Stella-Jones Announces Third Quarter Results and Updates 2023-2025 Financial Objectives by GlobeNewsWire
- BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024 by GlobeNewsWire
- WW International, Inc. Announces Third Quarter 2024 Results by GlobeNewsWire
- Cellebrite Announces Third-Quarter 2024 Results by GlobeNewsWire
- EQS-News: beaconsmind Group baut Geschäftsfeld Healthcare weiter aus und gewinnt Renafan als Neukunden by EQS Group AG
- Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference by GlobeNewsWire
- Vertex Announces Third Quarter 2024 Financial Results by GlobeNewsWire
- The ODP Corporation Embarks on a New 10-Year, $1.5B Transformative Partnership with Nationally Recognized Strategic Reseller by BusinessWire
- Perion Reports Third Quarter 2024 Results by BusinessWire
- Hepsiburada Announces the Second Bond Issuance of Hepsifinans by GlobeNewsWire
- Altimmune to Participate at Two Upcoming Investor Conferences by GlobeNewsWire